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ABSTRACT 
Ovarian hormones exert a strong influence on the brain; for example, estradiol 
(E2) has been found to modulate neuronal plasticity measured in vitro. To develop an 
understanding of how in vivo neuronal changes relate to the human brain, the non-human 
primate represents the closest animal model; however, no methodology is currently 
available for the continual, daily monitoring of E2 using non-human primates. The 
purpose of this thesis is to develop such a method. Daily sampling from 2 consecutive 
cycles in each of 3 rhesus macaques indicate that saliva can be used to detect the mid-
cycle peaks in E2. Saliva-serum correlations were low, suggesting that further refinement 
will be needed to increase this method's applicability to measures that require off-peak 
daily E2 fluctuations. An example includes the measurement of E2 concentration in 
conjunction with electrophysiology, to monitor the influence of estradiol levels on neural 
activity. 
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INTRODUCTION 
Estradiol is the most potent and pervasive member of a class of steroid hormones called 
estrogens. In females, estrogen plays a significant role in the development of sexual 
secondary characteristics, regulation of gonadtropin secretion, maintenance of bone mass, 
regulation of lipoprotein synthesis, aversion of urogenital atrophy and regulation of 
insulin responsiveness. Recently, estradiol has been implicated in the maintenance of a 
variety of cognitive functions as well as neuroprotection and neural plasticity (Cagnacci 
et al., 1992). The neural mechanisms underlying these events have yet to be fully 
understood as a result of limitations in the ability to directly manipulate neural activity in 
humans, and in the differences in ovarian function across species. As I will describe, the 
macaque is an important animal model for understanding the influence of ovarian 
hormones on the human brain. Whereas in humans, several different methodologies have 
emerged for measuring ovarian hormones, such as saliva collection and dried blood spots 
(Lewis, 2006), currently there is no available method for the continual daily sampling of 
ovarian hormones using rhesus macaques. In what follows, I will describe estradiol, how 
it contributes to ovarian and brain function, and issues surrounding the sampling of 
estradiol. 
Traditionally, estrogen has been cast as a "female hormone" most commonly 
associated with ovarian function, despite there being several extraglandular sites capable 
of synthesizing this hormone (Nelson and Bulun, 2001). These extraglandular regions 
include adipose, skin fibroblasts, bone and several different brain regions (Nelson and 
Bulun, 2001). These alternate sources may explain why estrogen has been implicated in 
physiological and patho-physiological roles in both men and women (Simpson et al., 
1999). 
Of the major classes of estrogens ( estradiol (E2), estrone, estriol), E2 is the most 
dominant throughout a women reproductive life; Estradiol (E2) is a C 18 steroid hormone 
that is approximately 10 times as potent as estrone and about 80 times as potent as estriol 
making it the predominant estrogen during a woman's reproductive years, both in terms 
of absolute serum concentrations and estrogenic activity (Comil et al., 2006). Moreover, 
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during menopause when circulating E2 is no longer the most prevalent, the change in 
steroid concentrations occurs as a result of diminished E2 synthesis and not as a result of 
an increase in alternative estrogen synthesis (Simpson et al., 1999). In males, estrogen is 
produced as an active metabolic product of testosterone and plays a critical role in 
spermatogensis and preserving bone density and mineralization (Simpson et al., 1999). 
Taken as a whole, the influence that estradiol has on the brain and body can be 
characterized by the source of estrogen synthesis and the reproductive state of the body. 
Systemic estradiol production through the HPG axis and the ovaries: 
The hypothalamic-pituitary-gonadal axis is primarily responsible for the systemic 
production of estradiol. The hypothalamus releases gonadotropin-secreting hormone 
(GnRH), which stimulates the anterior pituitary to release both luteinizing hormone (LH) 
and follicle-stimulating hormone (FSH) (General Biology. 2009). These hormones arrive 
at the ovaries, which stimulate the production of steroid hormones such as estradiol. 
Depending on the phase of the menstrual cycle (or the amount ofE2 present) the ovaries 
either stimulate or inhibit the response of the hypothalamus in a dynamic feedback loop 
thereby regulating estrogen production (Reproductive Biology. 2006). During the 
follicular phase of menstruation, FSH secrets increasing amounts of estrogen which in 
turn suppresses LH, resulting in the formation of a new layer of endometrium 
(Reproductive biology. 2006). During ovulation (when the egg has matured) estrogen 
begins to stimulate LH; these two opposing processes are thought to be mediated by two 
classes of different estrogen receptors, alpha and beta respectively, with the former 
controlling the negative feedback loop and the latter the positive one (Reproductive 
Biology, 2006). The increase in LH causes the release of the egg from the wall of the 
follicle, which eventually becomes the ovum (Reproductive biology. 2006). At the time 
of the luteal phase, large an amount of progesterone is secreted, causing a secondary rise 
of estrogen in terms of absolute serum concentrations (Reproductive biology. 2006). It is 
the fall of progesterone during this phase that ultimately triggers menstruation. 
Estradiol' s production in the ovaries begins in the internal cells of the ovaries 
(General Biology. 2009). After a side chain cleavage and using the delta-5 or the delta-4 
pathway, synthesis of androstenedione occurs from cholesterol (Simpson. 1999). This 
compound crosses the basal membrane into the surrounding granulosa cells, where it is 
converted to estrone or estradiol, either immediately or through testosterone (Simpson. 
1999). The conversion of testosterone to estradiol, and of androstenedione to estrone is 
catalyzed by the enzyme aromatase (Simpson. 2009). 
Local estrogen biosynthesis: 
I. Adipose and skin 
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A key factor in the local production of estrogen relates directly to the availability 
of precursor C 19 steroids for the aromatization to estrogens in peripheral tissues (Labrie 
et al. 1998). Aromatase expressions in adipose and skin tissue are capable of producing 
estrogen in large enough concentrations to be measured in circulating blood (Nelson and 
Bulun. 2001). Hemsell et al (1996) were the first to demonstrate human adipose as a 
major source of estrogen production. They showed that age-related increases in estrogen 
concentrations were associated with increases in aromatase and mRNA activity in adipose 
tissue, specifically fibroblasts (Nimrod et al. 1975). Aromatase expression in adipose is 
under the control of promotor 1,4 which is regulated by cytokines and glucocorticoids 
(Agarwal et al. 2006). Specific increases in aromatase expression were the result of 
increases in aromatse expression per fibroblasts that occurs with increasing age. 
The skin also synthesizes estrogen. Aromatase in the skin is expressed 
predominantly in hair follicles and sebaceous glands, however the exact origin of cell 
types is not known (Sawaya et al. 1992). Furthermore, the expression of 17-b 
hydroxysteroid dehydrogenase type 1, the enzyme responsible for catalyzing the 
conversion between estrone to estradiol has been found in skin providing further support 
that both skin and adipose are significant sites of peripheral estrogen producti:on (Nelson 
and Bulun. 1999). 
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II. Bone and Brain 
Local estrogen production in bone plays a significant role in maintaining bone 
mineralization and the prevention of pathological conditions such as osteoporosis in both 
men and women (Simpson et al. 1999). 
Estrogen can reach the brain via two pathways: the blood brain barrier or through 
aromatase found locally within the brain (Bake and Sohrabji. 2004). Enzymatic 
precursors necessary for estrogen production have been found in several different brain 
regions including the hypothalamus, prefrontal cortex, amygdala and hippocampus 
(Comil et al. 2006). Estrogen effects in the brain would appear to underlie several notable 
changes in cognition and behavior. For example, ERT (estrogen replacement therapy) 
significantly improves cognition, reduces the risk of developing progressive dementia and 
decreases the severity of preexisting dementia (Yaffe et al. 1998). 
Ovarian Hormone Sampling 
Saliva: 
Saliva is a variable and complex fluid playing a role in a plethora of biological 
functions ranging from oral health to homeostasis (Lewis. 2006). Saliva is not a simple 
ultrafiltrate of plasma; it has an active component requiring the formation of energy 
(Vining and McGinley. 2010). Salivary indexes ofbioactivity depend critically on prior 
knowledge of salivary gland physiology, fluid composition and mechanism of formation. 
There are three major salivary glands that predominate the production of saliva; the 
paratoid, submandibular and sublingual (Simpson. 1999). Smaller portions of saliva are 
produced by buccal glands, which are numerous in the inner lining of the mouth (Vining 
and McGinley. 1987). Salivary flow rate can affect the nature of the compounds found in 
saliva. Differences are evident in terms of ionic concentrations and protein quantities but 
not certain hormones; because of the rapid passive diffusion of steroid hormones into the 
saliva ducts, steroid hormones themselves are not different depending on salivary flow 
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rate (Kalk et al. 2002). Moreover, not all saliva is produced through glands; some 
fractions of saliva may also contain fluid of a non-glandular derivation originating from 
the oropharingeal mucosa, upper airway secretions and gastrointestinal pathways (Naglar. 
2002). Furthermore, salivary content and composition can show a significant discrepancy 
depending on whether or not saliva collection is basal or unstimulated with the latter 
being more similar in composition to plasma (Kalk et al. 2002; Chiappin et al. 2007). 
Stimulated saliva contains more calcium and bicarbonate, and has a higher pH than 
unstimulated saliva (Kalk et al. 2002; Chiappin et al. 2007). 
Of critical importance, saliva also contains variable quantities of plasma exudates 
resulting from oral abrasions and gingival crevicular fluid, which can interfere with 
hormone assay quantification (Chiappin et al. 2007). In healthy individuals, quantities of 
these exudates are low (0.5%) but can be significantly increased in persons with oral 
disease such as gingivitis (Chiappin et al. 2007). Saliva may contain food debris, blood 
derived molecules such as proteins and erythrocytes and leucocytes in the cases of oral 
disease (Aps et al. 2005). There are a variety of mechanisms allowing compounds to 
reach the salivary fluid. These include ultrafiltration through gap junctions whereby small 
molecules with low molecular weight such as water, ions and steroid hormones are 
permeable and their salivary concentrations generally are 300-3000 times lower than 
those observed in plasma (Chiappin et al. 2007). Plasma contents such as albumin can 
reach the oral cavity through the cervicular fluid or directly from the oral mucosa 
(Chiappin et al. 2007). 3) Transport through cellular membranes through diffusion 
(passive) or actively through protein channels can also account for the presence of various 
compounds found in saliva (Chiappin et al. 2007). Saliva is composed of six principle 
compounds: inorganic, organic, protein/polypeptide, lipids and hormone (Chiappin et al. 
2007). 
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Inorganic compounds: 
The composition of saliva is predominately made up of water and weak/strong 
ions. The principal secretion of fluid by salivary glands is plasma ultrafiltrate but in the 
salivary ducts themselves there is an active energy dependant recycling of Na+ and Cl 
resulting in fluids with a significantly lower ion concentrations relative to plasma. The 
presence of mineralcorticoid receptors in salivary ducts results in higher levels of salivary 
K + ions and lower levels of Na+ ions compared to plasma (APS, JKM. 2005). Ions found 
in saliva include Na+, K +, Cl, Ca2+, Hco3, Mg2+, Nh3 and their concentration is 
dependant on whether or not saliva collection was basal or stimulated (Agha-Hosseini. 
2006). 
Organic compounds: 
Non-proteins such as uric acid, bilirubin and creatinine are also present in saliva in 
small quantities. Lipids such as cholesterol and fatty acids such as alpha-linoleic and 
archidonic acid can also be detected. The concentration of fatty acids is positively 
correlated with dietary fatty acid intake (Agha-Hosseini. 2006). 
Protein/polypeptide compounds: 
Numerous different proteins have been identified in whole saliva; the most readily 
identified proteins are amylase, PRPs secretory IgA, and albumin (Chiappin et al. 2007). 
Functionally, proteins such as lysozyme, lactoferrin, lactoperoxidase, immunoglobins and 
mucins collectively protect the oral cavity; other proteins containing bacteria killing 
properties such as histatins and defensins play a broader role in maintaining overall 
health. The physiological circumstances in which saliva is collected can impact the 
concentrations of these proteins especially the immunoglobins. 
Hormones: 
Significance of hormone detection in saliva is completely dependant on the 
correlation between circulating levels in plasma and that found in the mouth. A-priori 
knowledge of the connection between free unbound and total-circulating fractions 
together with their specific binding proteins is needed before any salivary index of 
bioactivity can be established. Steroid hormone detection is the most common salivary 
application as several studies have previously found high correlations between fractions 
found in both serum and saliva (Chatterton et al. 2005). The most frequently studied 
salivary hormones include cortisol, testosterone, DHEA progesterone and estradiol 
(Chiappin et al. 2007). 
Steroid hormones in saliva: Estradiol (E2) 
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For almost 30 years salivary methods have been used to assess ovarian hormone 
function. Of critical importance for hormone application is the "bioavailibility" of that 
compound. The majority of steroid hormones in blood (95%-99%) are bound up by 
binding proteins such as sex hormone binding globulin (SHBG), cortisol binding globulin 
(CBG), and albumin. The remaining unbound fraction (1-5%) is commonly referred to as 
"free" hormone fraction, and is generally regarded as "bioavailable" (Read et al. 2006). 
Estradiol has been one of the most researched hormones to date and several studies have 
consistently demonstrated that estradiol can be precisely quantified in saliva and that 
salivary concentrations show high correlations with circulating serum fractions (Belkien, 
Bordt, Moller, Hano, and Nieschlag, 1985; Choe, Khan-Dawood, and Dawood, 1982; 
Lipson and Ellison, 1996; Lu, Bentley, Gann, Hodges, and Chatterton, 1999; O'Rourke 
and Ellison, 1993; Worthman, Stallings, and Hofman, 1990). For example, relatively 
high correlations between E2 in saliva and xxx (Shirtcliff et al., YEAR). Saliva and serum 
fractions show correlations as high as r=0.76 (Worthman et al 1990). Others have 
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reported salivary and serum correlations between 0.70-.80 (Lu et al., 1999). Salivary E2 
concentrations are considerably lower than serum concentrations and are estimated to be 
between 0.20 and 7.90% of that in the blood circulation (Lu et al., 1999). The difference 
in concentrations may lead to some of the unexplained variance in the sample 
correlations, if saliva concentrations border the lower limits of detection. Although 
concentrations in saliva are lower, the estrogenfound in saliva is unbound or "free" and is 
reflective of the bioavailable portion found in general circulation (Lu et al., 1999). 
Whereas this may make the saliva measurements more relevant, it could further introduce 
variability between serum and saliva sampling methods. 
The range of salivary estradiol concentrations is 0.8-14.3 pg/ml compared to the 
luminescent assay sensitivities which have lower detection limits of 0.3 pg/ml of E2.No 
salivary E2 index is avaialble for non human primates but given the similarities in 
reproductive features there is no reason to believe that non human primates will differ 
from humans with regard to salivary E2 concentrations. 
Dried blood spots: Estradiol 
Dried blood spots (DBS) was first introduced in the 1960' s by Dr. Robert Guthrie 
who collected heel-prick blood spots in infants as a way of detecting phenylketonuria 
(Guthrie et al. 1963). Since its introduction DBS has been used in a variety of clinical 
settings to study various proteins and hormones (McDade et al., 2007). Similar to saliva, 
DBS has the advantage of being minimally invasive and having a repeatable nature of 
sampling relative to venipuncture. Whole blood collected from DBS is similar to blood 
collected via venipuncture with some notable exceptions: Firstly, whole blood is 
composed of a variety of liquid and cellular components, and centrifugation of these 
samples after venipuncture removes cellular components to produce serum. Whole blood 
dried on filter paper contains these components, which rupture upon reconstitution. This 
requires that prior information regarding the sensitivity of interference of the compound 
in question is required before clinical usefulness can be established. DBS is relatively 
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straightforward and sample collection can be done with minimal training unlike 
venipuncture which requires advanced skill in phlebotomy. Blood spot sample collection, 
has been used to reliably measure thyroid hormones (Waite, Maberly, and Eastman, 
1987), prolactin (Bassett, Gross, and Eastman, 1986; Worthman, Stallings, and 
Gubernick, 1994), androstenedione (Thomson, Wallace, and Cook, 1989), cortisol 
(Kraiem, Kahana, Elias, Ghersin, and Sheinfeld, 1980), and steroid hormones including 
estradiol (Shirtlcliff et al. 2000 and (Worthman and Stallings, 1997). Similar to salivary 
indices ofbioactivity, for DBS to have both research and clinical applications it must 
show high correlations with that of serum/plasma, which are the most common fluids 
used to quantify hormones. Worthman and Stallings (1997) report an extremely high 
correlation between estardiol collected from DBS and that from venipuncture (r=0.98); 
however, the results have been criticized on the account that scant amounts of information 
were available to guide researchers wanting to replicate their results. Shirtlcliff and 
colleagues (year) more recently replicated these results and demonstrated that E2 can be 
accurately measured and quantified using DBS reporting a correlation of r=0.96. 
Given that estradiol has been measured using saliva and DBS of humans, we hope 
to apply these methods to non-human primates for the daily monitoring of ovarian 
hormones across the menstrual cycle. The purpose of this study is to apply both salivary 
and dried blood spot methods to non-human primates. 
Non-human primates represent the animal model that most closely matches humans 
both in terms of neural structures, biochemistry, and reproductive system. Female rhesus 
macaques have comparable reproductive cycles to human females with a mean cycle 
length of 33 days (McDade 2007). Given the similarities in reproductive anatomy and 
nervous system structure, and their regular use as animal models in studies of neural 
function, rhesus macaques are the ideal animal models when trying to uncover the role 
steroid hormones are likely to have on the human brain. The majority of literatures 
pertaining to ovarian hormones have predominately used rodents as the chosen animal 
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model. Given the drastic differences between the reproductive systems of rodents and 
primates (rodents have estrous cycles) and as a result little extrapolation to humans can be 
done. Rehsus macaques like humans have 30 day menstrual cycles and comparable 
reproductive features making them far more similar then the nearesy common animal 
model. To my knowledge no methods are currently available for the continuous daily 
sampling of ovarian hormones in vivo using rhesus macaques. The gold standard for 
quantifying hormones using non-human primates (NHPs) is venipuncture. Given the 
number of viable veins available for sampling, bruising associated with the procedure and 
the use of sedatives (which can confound the biochemistry) venipuncture isn't a 
reasonable option for the daily monitoring of ovarian hormones in vivo over any extended 
period of time. This poses a significant barrier for physiologist's observing neural 
recordings daily over the course of months who are interested in monitoring hormone 
levels during recordings. The development of both salivary and dried blood spot methods 
would significantly benefit physiologists, making it possible for the first time to 
simultaneously monitor how day-to-day fluctuations at the endocrine level influence the 
neural signal and consequent behaviour. 
MATERIALS AND METHODS 
Subjects 
Three adult female rhesus macaques were tested (LU, AN, RI, all 6 years old). 
Procedures were approved by the York University Animal Care Committee and were 
performed in accordance with the Canadian Council on Animal Care. 
Training: Saliva 
11 
Salivary habituation was performed incrementally through increased levels of 
contact with the NHP. Initially, the first level consisted of the animal becoming 
accustomed to variable epochs of direct human contact. The macaque was seated 
comfortably with only the back portion of the NHP chair (Crist Instruments) opened; this 
allowed the NHP to move their hands and feet and rotate or make postural adjustments 
while at the same time restricting locomotion. The animal was trained to present their 
hands and feet and hold that position for 5-60 seconds in order to receive a fruit reward. 
At first, the animal was required to have her limb extended for a minimum of 5s without 
retraction. Retractions are defined as any pulling back against the contact, but the same 
procedure hold for sudden movements of the hands or limbs including swatting and 
grabbing before the command to release contact. During limb presentation, finger 
manipulations and hand/foot massages were given to accustom the NHP to direct human 
physical contact. With each successive trial, an additional 5 seconds was added until a 
maximum of 60 seconds was reached without any retractions. If errors occur, the trial 
begins from the previous success trial and no reward is given. For example, ifthe 
macaque behaves well for 45s then decides to retract, the previous 40s trial is repeated. 
Once the animal was able to passively present their limbs for a total of one minute 
without retraction habituation ended and the next level of contact was pursued. The next 
stage involved head and face habituation. 
Direct head/face manipulation was accomplished without the use of a salivary 
collection device. Following a similar protocol used for hand/foot contact, I would touch 
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the head with both my hands for 5s and immediately provide a fruit reward if no 
aggressive gestures were made. Aggressive gestures were defined as attempted biting, 
open mouth threats and sudden head jerks. Once the NHP was accustomed to contact 
around the head and mouth region the salivary collection device was introduced. Initially, 
the device was not put into the primate's mouth; habituation involved placing the device 
on the outside of the mouth while simultaneously grasping the head for support. For each 
trial the primate received a fruit reward for good behavior. 
Once the animal was comfortable with the saliva collection device on the exterior, 
attempts were made to insert the collection device into the interior pouch of the primate's 
mouth. Habituation began by grasping the NHP head for support and inserting the 
absorbent foam material directly inside the deep pouch for 5s after which a fruit reward 
was immediately given. Both sides of the mouth were sampled (5s each side) after which 
a short 3 minute break was given to accustom the NHP to the time needed to centrifuge 
the absorbent material between saliva collections. As was the case for the previous 
protocols, an additional 5 seconds was added each time the animal was successful until a 
maximum of 60s was reached without any retractions or aggressive gestures. During the 
course of saliva collection the animal needs to learn to behave in the absence of an 
immediate fruit reward. During the collection of saliva, no food or drink is given to the 
animal to avoid sample contamination. The same protocol was repeated with the 
exception that a fruit reward was not given immediately after each insertion; a large fruit 
reward was given each 15s that the absorbent material was inside the NHP mouth until a 
maximum of 60s was reached without the need for reward. This was repeated 4 times 
consecutively allowing the animal to get accustomed to the length of time needed to 
obtain the desired quantity of saliva. By the end of training the NHP did not receive any 
immediate rewards rather received a "lump sum" reward consisting of an entire fruit 
bowl. 
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Collection of saliva 
Previously unused 5ml polyethylene tubes were labeled and marked with a lml 
fill line; this ensured that the desired volume required for assaying samples in duplicate 
was obtained. Saliva was collected using specialized salivary absorbent material 
(SUPERSAL, Oasis Diagnostics Corporation, Vancouver). Absorbent material was 
attached to a 5-inch metal rod and securely tied using dental floss (Figure 1 ). Subjects 
received 5ml of cold water prior to saliva collection that was orally administered via a 
5CC syringe to remove any particles of food left over from the previous night. Supersal 
absorbent material was inserted into the deep interior pouch of the NHP for 1-minute 
intervals. Both the left and right pouch was sampled in duplicate (total of 4 insertions) to 
obtain the required 500ul-lml volume of saliva. After each trial the absorbent foam was 
removed from the animal's mouth and immediately centrifuged at 2000 x g for 4 minutes, 
to remove the saliva contents from the absorbent material. Saliva samples were collected 
daily for the duration of an entire menstrual cycle (-28 days). No samples were processed 
fresh; instead they were all immediately frozen and subsequently thawed for assay. On 
the day of the assay, samples were centrifuged at (2000 x g, 15min) in order to break 
down the mucopolysaccharides that can impede accurate pipetting. 
Saliva assay procedure 
Extraction of salivary hormone estradiol (E2) was accomplished using a 
commercially available human estradiol luminescence assay (AFFINITY Diagnostics 
Corp., Toronto) without the use of any modifications. Prior to assay, all materials, 
chemicals and reagents were allowed to reach room temperature (25 degrees Celsius) and 
vortexed to ensure sufficient mixing. All samples were processed in duplicate to identify 
potential pipetting errors. The wells of the microtiter plate are coated with donkey anti-
sheep antibody. 50µ1 of the standards, controls and saliva samples were pipetted into their 
respective wells. 50µ1 of freshly prepared enzyme conjugate (containing alkaline 
phosphatase conjugate, NaN3) is then added to each well in addition to 50µ1 of estardiol 
antiserum (containing 17-P-estradiol sheep antibodies, NaN3) before being covered by an 
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adhesive foil. The wells are incubated on an orbital shaker (400-600 rpm) at room 
temperature for 4 hours to allow for maximal binding. Incubation solution is then 
discarded and the plate is washed X4 with 250µ1 of wash buffer (containing Tris buffer, 
Tween, NaN3). Excess solution is additionally removed by tapping the inverted microtiter 
plate on a lint free paper towel. 50µ1 of chemiluminescence reagent AP ( acridan based 
substrate) was added into each well following a specific order and time delay. The 
relative luminescence unit (RLU) was then measured with a luminometer within 10 
minutes of substrate addition, following the same specific order and time delay. The 
obtained RLU of the standards (y-axis, linear) are plotted against their concentration (x-
axis, logarithmic) using prism (figures 1-6). The concentration of the samples can be read 
directly from the standard curve. The amount of hormone in the sample is inversely 
proportional to the RLU detected by the plate reader. 
Collection of serum: venipuncture 
The collection of whole blood was carried out by a licensed veterinary technician. 
All blood was collected via the femoral vein located on the animal's thigh. The NHP was 
sedated using dexdomitor ( dexmedetomidine) and a2-agonist, administered according to 
the manufacturer's preset standards (based on the animals weight), in addition to 0.2 ml 
ofketamine (well below actual calculated dosage). 2-3 ml of whole blood was collected 
and stored in a 5ml red-topped BD vacutainer with no additional additives. The animal 
was given antisedan (atipamezole) a2-antagonist in an equivalent dose as the dexdomitor 
to assist with the animal's recovery. Whole blood was then allowed to sit at room 
temperature for 10 minutes in order to allow for clotting. Blood was then immediately 
centrifuged for 15 min at (2000X g, 15min) to allow for serum separation. Serum was 
then extracted using a micropipette and stored at -20 degrees Celsius until day of assay. 
Animals were s~dated semiweekly for one month yielding a total of 8 serum samples. No 
samples were processed fresh; instead they were all frozen and thawed on day of assay. 
15 
Serum assay procedure 
Extraction of serum hormone estradiol (E2) was accomplished using a 
commercially available human estradiol ELISA (enzyme linked immunosorbent assay) 
provided by (Calbiotech Inc, Spring Valley CA) without the use of any modifications. 
Prior to assay, all materials, chemicals and reagents were allowed to reach room 
temperature (25 degrees Celsius) and vortexed to ensure sufficient mixing. All samples 
were processed in duplicate to be able to identify potential pipetting errors. 25µ1 of 
standards, controls and samples were allocated into the microtiter plate coated with goat 
anti-rabbit IgG antibodies. 100µ1 of estradiol-HRP conjugate and 50µ1 ofrabbit anti-
estradiol reagent were also added to each well before being covered by an adhesive foil 
and incubated at room temperature for 90 minutes. Incubation solution was then 
discarded and the plate was washed X3 with 300µ1 of wash buffer. Excess solution was 
additionally removed by tapping the inverted microtiter plate on a lint free paper towel. 
After incubation, 100µ1 ofTMB reagent was added to each well and gently mixed for 10 
seconds and incubated for 20 minutes at room temperature. The reaction was stopped by 
the addition of 100µ1 of stop solution to each well. The absorbance was measured 
spectrophotometrically at 450 nm within 15 minutes of applying the stop solution. Similar 
to the salivary assay, a standard curve was obtained by plotting the concentration of the 
standard (x-axis) versus the absorbance (y-axis). The amount of hormone in the sample is 
inversely proportional to the optical density detected by the plate reader. 
Training: DBS 
Salivary methods were established first, eliminating the need for incremental 
levels of contact needed to accustom the animal to direct human contact (refer above). 
The macaque was seated comfortably with only the back portion of the chair opened. The 
primate was trained to present her hands and feet initially for 2 min; a single digit is 
isolated and cleaned with alcohol. On a "count of 3", the digit is then gently pinched (to 
simulate the lancet device) after which a fruit reward is immediately given. The next 
stage involved training the primate to keep their limbs extended after delivery of the 
'lf. 
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noxious stimulus. After the pinch, the animal is trained to keep their limbs extended 
without retraction for a total of 2 minutes during which the finger is manipulated above a 
protein saver card that stores the blood drops. This was achieved by positively reinforcing 
the animal with a fruit reward for every successful 30s that the limb was extended without 
retraction. To accustom the macaque to the lancet device, variable needle depths were 
used (figure 2). The procedure is then repeated with the notable difference that the pinch 
is now substituted for the real lancet device. At first a small 28G needle depth (Unistik 2 
- yellow) is used; this is not adequate for drawing blood but was used to habituate the 
primate to the lancet device (table 1). This procedure was repeated until the animal was 
able to successfully complete the 4 min requirement needed to fill each blood spot. Next a 
23G lancet was introduced (Untistik 2 - blue) which was successful in drawing small 
amounts of blood. The same procedure was repeated until the primate was able to 
complete the entire 4 minutes without any retraction. Next, a 21 G lancet ( Surgilance -
Pink) was used to accustom the animal to a deeper lancet device before using the 18G 
lancet which was used for sample collection (see Table 1). 
Table 1: Lancet device technical specifications 
Supplier Gauge Depth Color Blood Flow 
Unitsick 3 28 2.2 Yellow 10-20ul 
Surgilance 21 2.8 Pink 40-60ul 
Surgilance 18 2.3 Blue 150-200ul 
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Collection of whole blood: Dried blood spot (DBS) 
Dried blood spot samples are collected on specialized filter paper cards (e.g., 
Whatman Protein Saver Cards). The cards are standardized to ensure blood its absorbed in 
a homogenous manner. This guarantees that all identical punches (3.5 mm whole punch) 
will provide an equal amount of blood. The subject's digit is sterilized using both a sterile 
cotton gauze and alcohol. The finger is then pricked using an automated glucose lancing 
device designed specifically to minimize pain and discomfort. When the blood begins to 
flow the first drop is wiped away as it may contain possible sources of contamination 
such as tissue fluids. The remaining drops are then allowed to freely drop onto the protein 
saver card. It is important not to physically touch the digit to the filter paper. Only one 
drop of blood is collected per dry blood spot. Protein saver cards are then placed in a gas 
impenetrable bag with a desiccant. Samples are then stored at -20 degrees Celsius until 
assay. Analysis of DBS samples was beyond the scope of this thesis; here, I established 
that collection procedures for DBS are a viable alternative to saliva collection procedures. 
Analysis 
Standard curves were generated individually for both saliva and serum assays (12 
in total). A two-phase exponential decay was used to best fit the data and to extrapolate 
samples values from the standard curve using Graphpad (Prism). The precision of the 
assays was calculated using both the inter/intra coefficients of variation (see Table 2). 
Peaks would be considered consistent if they occurred within a few days of the same date 
following the onset of the last cycle. Pearson's correlation coefficient was then used to 
determine the degree of correlation between saliva and serum samples that were collected 
on the same days. 
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RESULTS 
Saliva samples were collected daily for the duration of two consecutive menstrual 
cycles. Each menstrual cycle consisted on average of a 3 0-day cycle followed by menses. 
In total 180 salivary samples and 48 serous blood samples were analyzed and quantified 
for E2 (see table 1 ). Standard curves were highly repeatable, yielding a mean correlation 
of r=0.98 for saliva and r=0.99 for serum respectively (see figures 1-7). Serum-saliva 
correlations varied depending on the individual; NHP 1 and 2 (AN and RI) showed the 
highest serum-saliva correlation r=0.53 and r=0.49 respectively, whereas NHP 3 (LU) 
showed the lowest correlation r= 0.19. Despite weak correlations, E2 peaks were 
consistently observed mid-cycle for all three non-human primates (see Figure 8). The 
precision of the assays can be seen in the inter/intra coefficients of variation (see Table 2). 
Table 2: Salivary and serum assay precision. CV: coefficient of variation, (% ). 
NHP 
NHP 1 (TI) 
NHP 2 (RI) 
NHP 3 (LU) 
Inter-assay CV 
11.7 
22.4 
15.3 
Intra-assay CV 
8.9 
5.7 
6.0 
Table 3: Saliva-Serum Sampling Dates 
NHP Saliva start/end Serum sample DBS start,/finish 
date 
Antigone:(NHP1) Start: January 25th 2011 Semi-weekly Start: January 25th 2011 
Ripley: (NHP2) 
Lucy: (NHP3) 
Finish: December 25th 
2011 
Start: January 25th 2011 Semi-weekly 
Finish: December 25th 
2011 
Start: January 25th 2011 Semi-weekly 
Finish: December 25th 
2011 
Finish: December 25th 
2011 
Start: January 25th 2011 
Finish: December 25th 
2011 
Start: January 25th 2011 
Finish: December 251h 
2011 
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Figure 1. Salivary standard curve for the first cycle of NHPl(Antigone). (Top) The 
standard curve depicting the relative luminance units observed as a function of 
standardized estrogen concentration, in pg/ml. (Bottom) curve fit results. 
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Figure 2. Salivary standard curve for the second cycle of NHPl(Antigone). (Top) 
The standard curve depicting the relative luminance units observed as a function of 
standardized estrogen concentration, in pg/ml. (Bottom) curve fit results. 
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Figure 3. Salivary standard curve for the first cycle of NHP2 (Ripley). (Top) The 
standard curve depicting the relative luminance units observed as a fulllction of 
standardized estrogen concentration, in pg/ml. (Bottom) curve fit results. 
3 
0:: 
Rl(1 ): Standard Curve 
200000 
0 .... --...... ---.--------.... ---.---.--..... 
0 10 20 30 40 50 60 70 
E2 concentration pg/ml 
Two phase exponential decay 
Best*fit values 
SPAN1 
K1 
SPAN2 
K2 
PLATEAU 
Halflife_1 
Halflife_2 
Std. Error 
SPAN1 
K1 
SPAN2 
K2 
PLATEAU 
95% Confidence Intervals 
SPAN1 
K1 
SPAN2 
K2 
PLATEAU 
Halflife_1 
Halflife_2 
Goodness of Fit 
125251 
0.06018 
30825 
0.4393 
17455 
11.52 
1.578 
59890 
0.04906 
64649 
1.074 
14628 
* 132500 to 382958 
0.0 to 0.2713 
*247400 to 309009 
0.0toS.062 
45490 to 80401 
Degrees of Freedom 2 
R2 0.9876 
22 
23 
Figure 4. Salivary standard curve for the second cycle of NHP2 (Ripley). (Top) The 
standard curve depicting the relative luminance units observed a;s a furnction of 
standardized estrogen concentration, in pg/ml. (Bottom) curve fit results. 
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Figure 5. Salivary standard curve for the first cycle of NHP3 (Lucy). (Tap) The 
standard curve depicting the relative luminance units observed as a funrction of 
standardized estrogen concentration, in pg/ml. (Bottom) curve fit results. 
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Figure 6. Salivary standard curve for the second cycle of NHP3 (Lucy). (Top) The 
standard curve depicting the relative luminance units observed as a function of 
standardized estrogen concentration, in pg/ml. (Bottom) curve fit results. 
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Figure 7.Serum estradiol concentration as a function of cycle sample number. 
Results are shown from NHPl in green, NHP2 in blue and NHP3 in red. 
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Figure 8: Average salivary estradiol concentration as a function of cycle day, aligned 
to E2 peak. Results are shown from NHPl in green, NHP2 in blue and NHP3 in red. 
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DISCUSSION 
The present investigation is the first methodological study in which ovarian 
hormones in macaques have been collected from biological media such as saliva and 
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dried blood spots (DBS). Three rhesus macaques were trained for both salivary and dried 
blood spot collection. Saliva was successfully extracted from the inner portions of the 
non-human primate's mouth and quantified using a luminescent-based immunoassay. 
Salivary estradiol did not correlate strongly with serum samples collected via 
venipuncture. Despite low correlations with serum samples, salivary E2 peaks were 
visible in all three non human primates during an appropriate time window for ovulation, 
suggesting that the assay was able to detect biological fluctuations when concentrations 
were at their highest (see Figure 8). In this field, blood serum is considered to be the 
'gold standard' for the quantification of E2. To date, only one published study 
(Thomspon, et al. 1999) has successfully employed daily E2 measurements in macaques 
for the purpose of quantifying ovarian hormones. The authors successfully trained non-
human primates to voluntarily present their hands for venipuncture without restraints or 
medical sedation. The duration of Thompson's study was a single menstrual cycle, 
therefore the sample collection period lasted no more than 30 days. Although Thompson 
and colleague's innovative approach introduced a viable method for daily quantification 
of E2 levels, this methodology is still unsuitable for many types of neural and behavioural 
experiments in macaques, which often extend beyond one-month durations. Use of such a 
procedure daily for long durations would be difficult given the limited number of veins 
available for sampling, particularly following bruising associated with the process of 
venipuncture. Moreover, drawing blood directly from a vein of a non-sedated animal adds 
additional hazards on the part of the phlebotomist and requires considerable training to 
avoid hemolysis of the serous contents. Luminescence based assay kits for the 
quantification of estradiol are extremely sensitive to extraneous blood components and 
can void the results if efforts are not in place to prevent any form of blood contamination 
during the separation of whole blood to serum. Taken as a whole, venipuncture is an 
unattractive method for the daily sampling of ovarian hormones in vivo using non-human 
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primates involved in tasks that last longer than one month. Other methods for observing 
ovarian hormones include temperature monitoring and changes in perinea! tumescence; 
however, studies have failed to consistently demonstrate both the reliability and validity 
of such approaches (Watman. 2006). 
Bridging the methodological gap, in particular, measuring ovarian hormone levels 
in macaques, is warranted in light of recent discoveries linking ovarian hormones to 
numerous aspects of neural function. Several lines of research in humans have 
demonstrated that estrogen levels can have significant effects on perception and memory 
(Esposito et al. 2011) and may be neuro-protective against pathologies associated with 
aging and stroke (Sherwin et al. 2007). Moreover, dramatic changes in brain anatomy and 
function are associated with ovarian hormones applied in slice in rodent models. Because 
several avenues of neural investigation rely on techniques that record neural responses 
continually over the course of weeks to months, any ovarian hormone sample collection 
method that cannot be successfully administered on a daily basis over the course of 
several months' limits the scope of prospective studies. 
Saliva collection summary 
All 3 non-human primates showed similarities in terms of absolute salivary E2 
concentrations (Figure 7). Moreover, all three showed the prototypical peaks 
characteristic of estradiol during both the ovulatory and luteal phase respectively, as 
measured using regularly cycling human females (figure 9) (Chiappin et al. 2007). 
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Figure 9: Human saliva estradiol concentration as a function of cycle 
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Both the consistency of E2 values across animals, in addition to the biphasic peaks 
seen throughout the cycle, suggest that saliva methods were reflective of true underlying 
biological hormonal activity (figure 7). As previously mentioned, this was first time that 
salivary methods have been applied to a non-human primate population; as a result no 
prior range of expected concentrations could be used as reference, and this work 
contributes to our understanding of expected fluctuations in salivary estrogen in 
macaques. Salivary estradiol concentrations were significantly higher than values 
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reported in the human literature (figure 5 and figure 9). Despite detecting estradiol peaks 
from saliva samples, salivary E2 values did not correlate with serum fractions collected 
throughout the cycle, therefore saliva samples cannot be fully verified as a useful index of 
ovarian hormone function. The lack of a strong correlation with serum samples may be 
due to several non-mutually exclusive factors. First, luminescent-based immunoassays are 
extremely sensitive to blood contamination, even at miniscule quantities. Non-human 
primates pouch large quantities of food and play with sharp plastic toys, which over time 
may have resulted in small unnoticeable abrasions inside the oral cavity. No empirical 
method was in place for quantifying blood found in saliva samples and so microscopic 
contaminations could not be objectively ruled out and may have contributed to the 
elevated saliva values and low serum-saliva correlations seen across all three non-human 
primates. Second, only one type of commercially available kit was used for assay and 
differences in antibody selectivity and sensitivity may have been a contributing factor. 
For example, no method was in place to quantify organic contents found in saliva and 
there may have been other compounds present, which interfered with the precision of the 
assay. Two out of the three macaques used for this study showed remarkably consistent 
menstrual cycles. One had highly abnormal cycles and heavy uterine bleeding associated 
with menses that were clearly different from the other two monkeys. Interestingly, this 
animal (LU) showed a remarkably different serum hormone profile relative to the other 
two individuals. 
Salivary methods offer at least three major benefits over previous sampling 
procedures: repeatability, non-specificity, and accuracy. One, the present design is 
repeatable. When using blood samples, daily venipuncture over the long term induces 
hematomas, which in turn is likely to result in hemolysis (the release of erythrocytes), 
which contaminates the sample upon separation of whole blood to plasma. By contrast, 
saliva sampling can be repeated daily - or several times per day - throughout several 
consecutive menstrual cycles without the need for separation, thus simplifying the 
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experimental procedure. Two, saliva sampling is non-specific. Saliva contains a diverse 
array of compounds such as lipids and proteins making this method applicable to several 
lines of investigation extending beyond estradiol sampling. Three, having the ability to 
conduct multiple determinations from a single subject statistically enhances the accuracy 
of corresponding results. An additional benefit is the minimal invasiveness of the 
procedure, which does not require the use of any restraint, or sedation, which has the 
potential for confounding the animal's biochemistry. All of these advantages make 
salivary sampling a viable candidate for the daily sampling of ovarian hormones in 
primates, though the accuracy of off-peak values needs to be addressed. Ultimately, this 
method can still be used for non-specific quantification ofE2 as mid-cycle peaks were 
consistently detected; for example, if an underlying hormonal imbalance or pathology is 
suspected samples can be collected to determine if the profile differs from other 
individuals in the group and thus serving as a diagnostic function 
DBS collection 
One of the advantages of training non-human primates for saliva sampling 
procedures is that once successfully completed, the animal will have become sufficiently 
habituated to human contact such that both blood and saliva sampling is possible. 
Hormones collected via saliva and dried blood spots (DBS) reflect different circulating 
fractions; salivary hormones are thought to represent free unbound hormones while DBS 
reflect fractions found in circulating blood where up to 97% is inactively bound to sex 
binding globulin hormone (SBGH) (Kreizman et al. 2010) therefore each method can be 
used selectively depending on the research question at hand. Given that venipuncture is 
the gold standard for E2 quantification it should be noted that DBS shows great potential 
in being both highly specific and accurate in terms of quantifying E2. DBS uses serum for 
assays (like venipuncture) however obtaining adequate sample volume (50 ul) from a 
blood spot has proven to be difficult especially given the padding on the non human 
primates hands and feet, Further work is needed to develop methods to obtain larger 
aliquots of blood during the procedure. 
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Future Directions 
Salivary and DBS hormone collection in macaques are novel techniques that show 
potential for daily hormone sampling. Although nearly half of the population is subject to 
fluctuating ovarian hormones, almost no research has investigated how these hormones 
change neural function in the brains of behaving animals, much less in non-human 
primates, which are the research model that most closely matches humans. The 
development of this method will allow for the first time daily saliva sampling of 
circulating hormones, which can then be used simultaneously in supplement with other 
physiological methods such as EEG and electrophysiology providing a more 
comprehensive picture on the question at hand. Although one of the methods isn't yet 
suitable for daily measurements, the other method (DBS) may be a good alternative, and 
saliva sampling may be useful for other uses of E2 measurements such as cycle regularity 
and hormonal disorders. The paucity of data on hormone sampling in non-human 
primates and the far-reaching health implications for human and non-human primates, 
alike, suggest that this is an important technique to pursue. 
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